Investors & Media

We’re ready to put children
with cancer first

Investors & Media

We’re ready to put children
with cancer first

Company Overview

Day One Biopharmaceuticals is a commercial-stage biopharmaceutical company that believes when it comes to pediatric cancer, we can do better. The Company was founded to address a critical unmet need: the dire lack of therapeutic development in pediatric cancer. Inspired by “The Day One Talk” that physicians have with patients and their families about an initial cancer diagnosis and treatment plan, Day One aims to re-envision cancer drug development and redefine what’s possible for all people living with cancer—regardless of age—starting from Day One.

Corporate Presentation
Share Price

Jun 20, 2024 7:33 AM EDT
Data Provided by Refinitiv. Minimum 15 minutes delayed.
Investor Contact

Investor Relations
investors@dayonebio.com

Media Contact

Laura Cooper
Media@dayonebio.com